Supplement to November December 2014 CME ACTIVITY - Retinal degeneration - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-12-18 14:21:55 Angiology Vascular endothelial growth factor Ranibizumab Bevacizumab Macular degeneration Choroidal neovascularization Genentech Diabetic retinopathy Retinal haemorrhage Medicine Ophthalmology Vision		Supplement to November/December 2014 CME ACTIVITY Add to Reading List Source URL: www.retinatoday.com Download Document from Source Website File Size: 1,19 MB Share Document on Facebook

	Napoleone Ferrara, Genentech DocID: 1uIWu - View Document
	Microsoft Word - Genentech 2010 ltr v2.doc DocID: 1uy56 - View Document
	U.S. Patent No. 7,838,512, Claims 1-3 & 5-6 Petition for Inter Partes Review Filed on behalf of OSI Pharmaceuticals, LLC and Genentech, Inc. By: David L. Cavanaugh, Reg. No. 36,476 (Lead Counsel) Wilmer Cutler Pickering DocID: 1tr4e - View Document
	Zermatt2016_final_program DocID: 1r5GG - View Document
	PDF Document DocID: 1qP5u - View Document